New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Lantern Pharma Inc. (LTRN) vs Heatwurx Inc. (PCSA)
- Lantern Pharma Inc. LTRN 0.28 −15.15%
- Heatwurx Inc. PCSA 1.67 −1.76%
Lantern Pharma Inc. and Heatwurx Inc. are both Biotechnology companies. Lantern Pharma Inc. and Heatwurx Inc. are of similar size ($4.9M and $4.8M). Across the 8 metrics below, Heatwurx Inc. leads on 5 and Lantern Pharma Inc. on 3.
Valuation
Profitability
| Metric | LTRN | PCSA | Biotechnology median |
|---|---|---|---|
| Gross margin | 0.00% | 0.00% | 70.18% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (250.59%) | 220.06% | (51.58%) |
| Return on assets | (124.41%) | (203.76%) | (45.91%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack